Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Partners With Health Canada On E-Submission Pilot

Executive Summary

The pilot will allow manufacturers to use the same digital application format for regulatory consideration by both agencies. 

You may also be interested in...



Device Recalls Up, Manufacturing Defects Called The Culprit

Medical device recalls have ticked up this year because of defects in manufacturing, according to a report from Sedgwick.

FDA Finalizes Electronic Submissions Guidance

The guidance document explains the history of and requirements for electronic submissions of 510(k)s. 

DOJ: False Claims Settlements Neared $2.7Bn In 2023

The government collected $2.68bn from settled False Claims Act cases last year, the US Department of Justice said. Another 12 device-related cases were announced in February alone.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT147515

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel